Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 226 to 240 of 320 results for antibiotics

  1. Care setting: What is the clinical and cost effectiveness of different models of care for the prevention and treatment of early-onset neonatal infection?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  2. Clinical epidemiology of Lyme disease in the UK:- What are the incidence, presenting features, management and outcome of Lyme disease in the UK?

    population-basedstatistics. These statistics would enable interventions such as antibiotic treatment and service improvements to be...

    Research recommendation
    Published
    21 November 2018

  3. Preterm prelabour rupture of membranes: What are the relative risks and benefits of induced labour versus expectant management in women whose membranes have ruptured spontaneously between 34 and 37 weeks?

    membranes have ruptured, avoiding the need for induction. The value of antibiotic therapy and the administration of corticosteroids to...

    Research recommendation
    Published
    15 December 2021

  4. Nerve graft for corneal denervation (IPG729)

    Evidence-based recommendations on nerve graft for corneal denervation. This involves attaching a healthy nerve to the damaged cornea to improve healing.

    Interventional procedures guidance
    Published
    29 June 2022
    View recommendations

    Sections for IPG729

  5. Image-guided radiofrequency excision biopsy of breast lesions (IPG308)

    Evidence-based recommendations on image-guided radiofrequency excision biopsy of breast lesions. This involves inserting a probe that uses radiofrequency energy to cut through the breast internally, and removing the lump with a small area of surrounding tissue to test for cancer.

    Interventional procedures guidance
    Published
    22 July 2009
    View recommendations

    Sections for IPG308

  6. i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)

    NICE has developed a medtech innovation briefing (MIB) on i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department

    Medtech innovation briefing
    Published
    9 September 2015

  7. Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction (IPG653)

    Evidence-based recommendations on valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) for aortic bioprosthetic valve dysfunction in adults. This involves placing a new bioprosthetic valve inside a failing bioprosthetic valve.

    Interventional procedures guidance
    Published
    26 June 2019
    View recommendations

    Sections for IPG653

  8. Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis (IPG746)

    Evidence-based recommendations on tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. This involves inserting a catheter under the skin in the abdomen to drain excess fluid when needed, at home or in community care. The aim is to reduce the need for hospital admissions and improve quality of life.

    Interventional procedures guidance
    Published
    23 November 2022
    View recommendations

    Sections for IPG746

  9. Open prenatal repair for open neural tube defects in the fetus (IPG668)

    Evidence-based recommendations on open prenatal repair of open neural tube defects in the fetus. This involves open surgery through the woman’s abdomen to close the gap in the baby’s spine.

    Interventional procedures guidance
    Published
    29 January 2020
    View recommendations

    Sections for IPG668

  10. Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related quality of life of the baby's family?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  11. Risk factors for and clinical indicators of early-onset infection: What is the risk of early-onset neonatal infection with maternal obesity and how does this change with increasing body mass index?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  12. Risk factors for and clinical indicators of early-onset infection: What is the accuracy of clinical prediction models for early-onset neonatal infection in the UK and what is their effectiveness in guiding management in the baby?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  13. Risk factors for and clinical indicators of late-onset infection: What is the accuracy of new or existing clinical prediction models for late-onset neonatal infection in the UK and what is their effectiveness in guiding management: - for babies already on a neonatal unit? - for babies admitted from home?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  14. Lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema (IPG785)

    Evidence-based recommendations on lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema in adults. This involves diverting some of the lymphatic vessels around where lymph nodes have been removed to nearby veins.

    Interventional procedures guidance
    Published
    16 April 2024
    View recommendations

    Sections for IPG785

  15. myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

    NICE has developed a medtech innovation briefing (MIB) on myAIRVO2 for the treatment of chronic obstructive pulmonary disease .

    Medtech innovation briefing
    Published
    1 October 2018